EIF4EBP1 and mantle cell lymphoma: These results are consistent with other studies in solid tumors that demonstrated inferior patient outcome when the tumor cells overexpressed eIF4E.[19] The positive expression of 4E-BP1[20] and eIF4E[17] in MCL and DLBCL tumors by IHC has previously been reported but without relationship to patient outcome.